Treatment for retinal diseases, including neovascular age-related macular degeneration, includes anti-vascular endothelial growth factor (VEGF) injections, which attenuate the capacity of VEGF to bind to VEGF receptors. Here, VEGFA is linked to Abnormal retinal morphology.